BlackSky’s core risk is sequencing: it must fund and deploy more
Gen-3 capacity, commission it smoothly, and convert that capacity into recurring higher-quality revenue before budget timing, export friction, or
dilution blunt the compounding. The technology is real and demand is real; the fragile part is turning that into durable economics fast enough to justify today’s valuation.